Section 9 wrestling to conduct boys Division II tourney at F.D. Roosevelt. Sunday start time is 10:30 a.m. Here are the top ...

"In the past, patients living with liver cancer had few treatment options and faced poor prognoses," said Andrea Wilson Woods ... the next wave of biopharma. Merck KGaA is talking to SpringWorks ...

Merck booked just under $600 million last year in alliance revenues from the pair, but its attention is now moving to new therapies including sotatercept, a TGF-beta-targeting PAH drug Merck ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The president will today announce 25 percent tariffs on all steel and aluminum imports as his long-threatened global trade war heats up. Trump told reporters aboard Air Force One on Sunday afternoon ...

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) has been assigned an average rating of “Moderate Buy” from the seven brokerages that are currently covering the company, Marketbeat reports. Two ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Boyz II Men visited Capitol Hill to meet with top lawmakers on the American Music Fairness Act, with a letter signed by over ...

Organon & Co (OGN) reported its financial results for the fourth quarter of 2024, revealing stable revenue figures in line with forecasts and a slight miss on earnings per share (EPS). Despite this, ...

Antibodies and related products are the fastest growing class of therapeutic agents. By analysing the regulatory approvals of IgG-based biotherapeutic agents in the past 10 years, we can gain ...

Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.